New China Life Insurance Company Ltd. (601336) Earnings Call Transcripts
New China Life Insurance Company Ltd.'s Latest Earnings Call - March 30, 2026
In the fiscal year 2025, New China Life Insurance Company Ltd. reported robust financial results, with total revenue reaching RMB 157.8 billion, up 19% year-over-year, and net profit soaring to RMB 36.3 billion, an increase of 38.3%. The company highlighted significant growth in gross written premiums, which rose by 14.9% to RMB 195.9 billion. Management maintained a positive outlook for 2026, focusing on high-quality growth and strategic initiatives to enhance product offerings and customer engagement, while emphasizing the importance of transitioning to participating insurance products.
Reported metrics
| Metric | Value |
|---|---|
| Total Revenue | RMB 157.8 billion (beat) |
| Net Profit | RMB 36.3 billion (beat) |
| Gross Written Premiums | RMB 195.9 billion (beat) |
| Total Assets | RMB 1.9 trillion (beat) |
| Total Investment Income | RMB 104.3 billion (beat) |
| Total Market Value | RMB 200 billion (positive) |
Guidance from management
Management signaled a commitment to high-quality growth in 2026, focusing on enhancing product offerings and customer engagement while continuing the transition to participating insurance products. They expect steady growth despite a challenging low-rate environment.
What analysts pressed on
Analysts expressed concerns about the sustainability of growth given the high base from previous years and the challenges posed by the low interest rate environment. They questioned how the company plans to maintain profitability while transitioning to participating insurance products.
Main topics on the call
- Strong Financial Performance — New China Life reported a net profit of RMB 36.3 billion, up 38.3% year-over-year, and total assets increased by 12.2% to nearly RMB 1.9 trillion. Management stated, "Our business performance has reached new heights, bui...
- Growth in Gross Written Premiums — Gross written premiums rose by 14.9% to RMB 195.9 billion, indicating strong demand for insurance products. Management noted, "We are confident on a high base, we can maintain a steady growth."
- Transition to Participating Insurance — Management emphasized the importance of transitioning to participating insurance, with sales reaching RMB 12 billion in 2025. They stated, "In 2026, we will continue our participating business transition, focusing on pro...
- Bancassurance Channel Growth — The bancassurance channel saw FYP growth of 52.3% to RMB 37.93 billion, with NBV increasing by 110%. Management highlighted, "Our bank insurance business has posted strong growth and has become an important engine to dri...
Read the full New China Life Insurance Company Ltd. transcript (March 30, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About New China Life Insurance Company Ltd.
New China Life Insurance Company Ltd. (601336) is a publicly listed company in the Insurance industry, within the Financials sector. It trades on SHSE and is based in CN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 11 calls on record spanning March 26, 2020 to March 30, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 11 New China Life Insurance Company Ltd. earnings call transcripts on record, spanning March 26, 2020 to March 30, 2026. Based on this history, New China Life Insurance Company Ltd. reports semi-annually. The most recent call on file is dated March 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- 601336
- Exchange
- SHSE
- Country
- CN
- Sector
- Financials
- Industry
- Insurance
- Calls on record
- 11
- First call
- March 26, 2020
- Most recent
- March 30, 2026
- Reporting cadence
- semi-annually
| Quarter | Date | |
|---|---|---|
| Earnings Calls | Mar 30, 2026 | Read transcript → |
| Earnings Calls | Aug 30, 2024 | Read transcript → |
| Earnings Calls | Mar 28, 2024 | Read transcript → |
| Earnings Calls | Aug 30, 2023 | Read transcript → |
| Earnings Calls | Mar 31, 2023 | Read transcript → |
| Q2 FY2022 | Aug 31, 2022 | Read transcript → |
| Earnings Calls | Mar 30, 2022 | Read transcript → |
| Earnings Calls | Aug 27, 2021 | Read transcript → |
| Earnings Calls | Mar 25, 2021 | Read transcript → |
| Earnings Calls | Aug 26, 2020 | Read transcript → |
| Earnings Calls | Mar 26, 2020 | Read transcript → |